FDA Approves First-of-Its-Kind Drug to Delay Type 1 Diabetes

Share
  • November 18, 2022

With type 1 diabetes, the body attacks itself. A person’s own immune system destroys the pancreas over time, leaving the critical organ unable to produce insulin and regulate blood sugar. Almost 1.9 million people, including about 244,000 children, live with the life-altering illness. It is a disease with no cure or…

Read more…

Source : FDA Approves First-of-Its-Kind Drug to Delay Type 1 Diabetes